AIIMS Delhi Partners to Advance Indian ALS Research Initiatives
The Department of Neurology at AIIMS New Delhi, collaborating with the ALSCAS Foundation India, hosted a global awareness event to address Amyotrophic Lateral Sclerosis. Medical experts and advocacy groups gathered to discuss evolving treatment strategies and unveil upcoming clinical research registries tailored specifically to the Indian population.
Key Highlights
- Over 150 participants including patients, clinicians, and researchers attended the neurodegenerative disease forum.
- Two distinct research initiatives are scheduled to debut at AIIMS during the third and fourth quarters of 2026.
- Target ALS is funding a natural history study that will officially begin operations in August 2026.
- A smartphone-based monitoring registry is slated for deployment between September 2026 and October 2026.
The Neuromuscular disorders team of the Department of Neurology, All India Institute of Medical Sciences (AIIMS), New Delhi, in collaboration with ALS Care & Support Foundation (ALSCAS) India, organised the Global ALS/MND Awareness Day event at AIIMS on 24 June 2026 to raise awareness about Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative Motor Neuron Disease (MND).
The event brought together over 150 patients, caregivers, neurologists, healthcare professionals, researchers, advocates, and members of the wider community to exchange knowledge, share lived experiences, and discuss evolving approaches to ALS/MND care and support.
The programme featured expert sessions by specialists from AIIMS on various aspects of ALS/MND, including understanding the disease, respiratory care, cognitive and behavioural changes, and palliative care. Speakers highlighted the importance of timely interventions, symptom management, respiratory support, and palliative care in improving the quality of life of individuals living with ALS/MND.
The programme also offered a glimpse into the future of ALS research at AIIMS. Two ALS studies are expected to commence shortly, including a natural history study, which is a Target ALS-funded project beginning in August 2026. The second is a smartphone-based ALS registry likely to be launched in September-October 2026.
The initiatives are expected to strengthen India-specific ALS research and contribute to a better understanding of the disease in the Indian context. The programme also highlighted ongoing efforts to expand opportunities for ALS clinical trials in India.
Future Outlook
Medical institutions across India are actively shifting toward digitized patient tracking to accommodate the growing need for localized clinical data. The upcoming digital registries and observational projects at AIIMS indicate a concerted push toward establishing robust baselines for South Asian genetic profiles in neurodegenerative tracking. These structural foundations are projected to streamline international clinical trial onboarding and accelerate therapeutic access for domestic patients over the next decade.
FAQs
What initiatives did AIIMS Delhi announce for ALS research?
AIIMS Delhi disclosed two upcoming medical studies designed to track the progression of the disease. These include a well-funded natural history project starting in August 2026 and a mobile-app registry launching in late 2026.
When did the Global ALS/MND Awareness Day event take place?
The collaborative event organized by AIIMS and the ALSCAS Foundation was held on site in New Delhi on 24 June 2026.
What medical focus areas were emphasized by the clinical speakers?
The specialists focused heavily on multi-disciplinary care management. Key topics covered included specialized respiratory therapy, cognitive behavioral adjustments, early diagnostic interventions, and localized palliative care strategies.
Who funds the new natural history study at AIIMS?
The observational natural history project launching in August 2026 is fully financed and supported by the international organization Target ALS.
